Ackman 'Throws In The Towel' – What's Next For Valeant?
Executive Summary
Valeant's prospects were dim with or without Pershing Square's continued backing, but at least one analyst says Ackman's departure sends a signal that business won't rebound at the Canadian specialty pharma any time soon.